European Commission Strongly Recommends the Use of Generic and Biosimilar Medicines to Ensure the Sustainability of Healthcare Systems

14 October 2016

Medicines for Europe welcomes the publication of the ‘Joint Report […]

Generic Medicines at the Heart of the French Public Health System

30 September 2016

Medicines for Europe strongly supports the French government campaign to […]

Generic Medicines save European Countries 100 Billion Euro per Year

28 September 2016

Lisbon, September 28, 2016 – Without the use of generic […]

European Health Ministers Call for More Competition in Pharmaceutical Markets

17 June 2016

Medicines for Europe will engage rapidly with Health Ministers across […]

IGBA Joins ICH and Welcomes the Positive Vote of the General Assembly

15 June 2016

Generic, Biosimilar and Value Added Medicines Industry Leaders Join Forces to Drive Access to Medicines Agenda

9 June 2016

During the next two days, the key pharmaceutical industry leaders […]

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Spain and Europe Join Forces To Bring Access To Generic Medicines To The Market

19 January 2016

Barcelona – At their joint Executive meeting in Barcelona today, the […]

Generic and Biosimilar Medicines Essential for Italian Healthcare System

8 January 2016

Brussels – Generic and biosimilar medicines represent an essential opportunity to […]